Shenzhen Stock Exchange: Genscript Biotech (01672) and Xizhi Technology (01879) will be included as eligible stocks for the Hong Kong Stock Connect under the Shenzhen-Hong Kong Stock Connect.
According to the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect" by the Shenzhen Stock Exchange, the list of eligible securities for the Hong Kong Stock Connect will be adjusted and come into effect on September 7, 2026.
On September 7, the Shenzhen Stock Exchange announced that, in accordance with the relevant provisions of the "Implementation Measures for Shenzhen-Hong Kong Stock Connect," the list of eligible securities for the Hong Kong stock connect has been adjusted and will take effect from September 7, 2026. The new additions include Galactech Pharmaceuticals (01672), Xizhi Technology (01879), and Baidu Group (09888), while NISSIN FOODS (01475), HAICHANG HLDG (02255), and SYNAGISTICS (02562) will be removed.
Related Articles
YUK WING GP(01536): Zeng Jiaxin has been appointed as Executive Director.
.png)
S.F. Holding (06936) spent HK$19.445 million on September 7 to repurchase 625,000 shares.
ONEWO (02602) repurchased 250,000 shares at a cost of approximately HKD 4.7258 million on September 7.
YUK WING GP(01536): Zeng Jiaxin has been appointed as Executive Director.
S.F. Holding (06936) spent HK$19.445 million on September 7 to repurchase 625,000 shares.
ONEWO (02602) repurchased 250,000 shares at a cost of approximately HKD 4.7258 million on September 7.
RECOMMEND
